![William Fodor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 31/05/2026
William Fodor is currently Chief Scientific Officer at Harvard Apparatus Regenerative Technology, Inc. since 2017.
Former positions include Chief Executive Officer at GlyGenix Therapeutics, Inc., Senior Director-Tissue Engineering at Alexion Pharmaceuticals, Inc., Senior Director-Product Development at ViaCell, Inc. from 2006 to 2008, and Associate Professor at the University of Connecticut from 2002 to 2005.
Education includes a doctorate from The Ohio State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Directeur Technique/Scientifique/R&D | 01/07/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Corporate Officer/Principal | 01/07/2008 |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2005 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic products for the treatment of cure metabolic disorders | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Harvard Apparatus Regenerative Technology, Inc.
 Harvard Apparatus Regenerative Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of medical devices | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlyGenix Therapeutics, Inc.
GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic products for the treatment of cure metabolic disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
